Annexon

Annexon ROIC

The Return on Invested Capital (ROIC) of Annexon (ANNX) as of Nov 7, 2026 is -96.33 %. In the previous year, Return on Invested Capital (ROIC) was -47.15 % — a change of 104.31% (lower).

ROIC

-96.33 %

YoY

104.31%

Last updated:

Return on Invested Capital (ROIC) of Annexon is 2025 -96.33 % . Return on Invested Capital (ROIC) of Annexon was 2024 -47.15 % . It decreases by 104.31% lower compared to the previous year.

The Annexon ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
-48.32 USD
Jan 1, 2019
-85.42 USD
Jan 1, 2020
-18.23 USD
Jan 1, 2021
-55.10 USD
Jan 1, 2022
-59.82 USD
Jan 1, 2023
-53.58 USD
Jan 1, 2024
-47.15 USD
Jan 1, 2025
-96.33 USD
The Annexon ROIC history
YEARROICYoY
-96.33 %+104.31%
-47.15 %-11.99%
-53.58 %-10.44%
-59.82 %+8.55%
-55.10 %+202.35%
-18.23 %-78.66%
-85.42 %+76.77%
-48.32 %-219.36%
40.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Return on Invested Capital (ROIC) of Annexon is -96.33 % in 2025.

Return on Invested Capital (ROIC) of Annexon changed from -47.15 % to -96.33 %, representing a 104.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Annexon since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Annexon with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Annexon

All Key Metrics — Annexon